Kinetic characterization of GES-22 β-lactamase harboring the M169L clinical mutation

J Antibiot (Tokyo). 2016 Dec;69(12):858-862. doi: 10.1038/ja.2016.48. Epub 2016 May 11.

Abstract

The class A β-lactamase GES-22 has been identified in Acinetobacter baumannii isolates in Turkey, and subsequently shown to differ from GES-11 by a single substitution (M169L). Because M169 is part of the omega loop, a structure that is known to have major effects on substrate selectivity in class A β-lactamases, we expressed, purified and kinetically characterized this novel variant. Our results show that compared with GES-116 × His, GES-226 × His displays more efficient hydrolysis of penicillins, and aztreonam, but a loss of efficiency against ceftazidime. In addition, the M169L substitution confers on GES-22 more efficient hydrolysis of the mechanistic inhibitors clavulanic acid and sulbactam. These effects are highly similar to other mutations at the homologous position in other class A β-lactamases, suggesting that this methionine has a key structural role in aligning active site residues and in substrate selectivity across the class.

MeSH terms

  • Acinetobacter baumannii / enzymology
  • Acinetobacter baumannii / genetics*
  • Amino Acid Sequence
  • Amino Acid Substitution
  • Anti-Bacterial Agents / chemistry
  • Anti-Bacterial Agents / pharmacology
  • Aztreonam / pharmacology
  • Carbapenems / pharmacology
  • Ceftazidime / pharmacology
  • Cephalosporins / pharmacology
  • Clavulanic Acid / pharmacology
  • Drug Resistance, Bacterial / genetics*
  • Hydrolysis
  • Mutation*
  • Penicillins / pharmacology
  • Plasmids / genetics
  • Protein Conformation
  • Substrate Specificity
  • Turkey
  • beta-Lactamase Inhibitors / pharmacology
  • beta-Lactamases / chemistry
  • beta-Lactamases / genetics*
  • beta-Lactamases / pharmacology*

Substances

  • Anti-Bacterial Agents
  • Carbapenems
  • Cephalosporins
  • Penicillins
  • beta-Lactamase Inhibitors
  • Clavulanic Acid
  • Ceftazidime
  • beta-Lactamases
  • Aztreonam